# Dupixent (dupilumab) — safety & injury context

> Clinical summary and reported injury patterns. Not medical advice.

**Canonical URL:** https://drugsmonitor.com/drug-info/dupixent-dupilumab-lawsuit
**Related case:** https://drugsmonitor.com/case/dupixent-dupilumab-lawsuit
**Last updated:** 2026-06-11

## Clinical context

Dupilumab is a biologic that blocks IL-4/IL-13 signaling and is used for atopic dermatitis, asthma, and other conditions. Post-marketing reports and litigation discussions have included ocular surface disease, keratitis, and vision-related harms in some patients—defendants dispute causation and labeling adequacy.

## Litigation context

Civil filings and MDL-style coordination vary by court; some matters remain in early pleading stages. Confirm current docket status with qualified counsel.

---

*Discuss symptoms and treatment with a licensed clinician.*